Market Research Hub

Nordics Seasonal Influenza Vaccine Market Analysis with Forecast Until 2022

According to the report, Sweden is having the highest seasonal influenza vaccine market share. In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 60 percent market share by 2022.


Albany, NY -- (SBWIRE) -- 05/04/2017 -- According to recent studies, Nordics Seasonal Influenza vaccine market enjoys the largest market share in Sweden. Along with Denmark, it holds nearly 70 percent market share as noted in 2016. For further detailed analysis, Market Research Hub (MRH) has added a fresh report titled as "Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination" to its vast report database. This research study provides a complete market analysis related to seasonal influenza vaccine covering 5 Nordic countries (Denmark, Finland, Iceland, Norway and Sweden), with a precise forecast outlook till 2022.

Request Free Sample Report:

Seasonal flu is a contagious respiratory illness caused by various influenza viruses that can infect the nose, throat, and lungs. It can cause mild to severe illness, and sometimes death; hence it is better to stay protected. This flu can spread through droplets and is difficult to distinguish from other viral or other bacterial causes. So the best possible way to be protected is through vaccination. Complications of flu can include bacterial pneumonia, ear infections, sinus infections, dehydration, and worsening of chronic medical conditions, such as congestive heart failure, asthma, or diabetes. Moreover, this virus in more prominent in colder areas posing a higher risk.

Initially, the report starts with the executive summary of the seasonal influenza vaccine market in the Nordic countries. Further, details related to the vaccinated population by child & adult is carefully mentioned in the report. The report is segmented by seasonal influenza vaccine market share, child vaccine market share and adult vaccine market share in the concerned regions. The report is a complete study which covers the specific countries namely, Denmark, Finland, Iceland, Norway, and Sweden.

In the later sections, the study pours light on the growth drivers which include, manufacturers plan to increase flu vaccine production, growing child & ageing population in the Nordic regions, rising healthcare expenditure share of the Nordic countries GDP and challenges that consist of regulatory challenges with new and novel influenza vaccines, lack of healthcare infrastructure and limited reimbursement and access to the vaccines is detail for complete and overall market analysis.

Browse Full Report with TOC -

Overall, the research is a full-proof collection of the complete data and table linked to seasoned influenza vaccine market which displays healthcare expenditure share by percentage of GDP for the Nordic countries during 2005-2015 and hence analyzing the market with its overall effect.

Check Other Related Reports -

Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021) -

Global Anti-Infective Vaccines Sales Market Report 2017 -

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074